USPTO Examiner GABR MOHAMED GAMIL - Art Unit 3771

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19213354DEVICES, SYSTEMS, AND METHODS FOR INTRALUMINAL PUNCTURINGMay 2025September 2025Allow401NoNo
19064641LAPAROSCOPIC ANASTOMOSIS DEVICES AND METHODS OF USE THEREOFFebruary 2025June 2025Allow400NoNo
19061275STENOSIS REPAIR USING LARYNGEAL FORCEPS HAVING MEASUREMENT SCALEFebruary 2025December 2025Allow920NoNo
19040898Fenestrated Balloon Catheter SystemJanuary 2025August 2025Allow620YesNo
19010570IN VIVO OCCLUSION AND CLAMPING INSTRUMENTJanuary 2025July 2025Allow710NoNo
18950236CORONARY ARTERY ROTATIONAL ATHERECTOMY INTERVENTION SYSTEMNovember 2024March 2026Allow1600NoNo
18882551SPECIMEN COLLECTOR FOR ROBOTIC MEDICAL SYSTEMSeptember 2024February 2026Allow1700NoNo
18810076INSTRUMENT RETRACTION FACILITATIONAugust 2024February 2026Allow1800NoNo
18796904PRESSURE PROFILE MAGNETIC COMPRESSION ANASTOMOSIS DEVICESAugust 2024February 2026Allow1800YesNo
18776647STENOSIS REPAIR USING LARYNGEAL FORCEPS HAVING MEASUREMENT SCALEJuly 2024August 2025Abandon1320NoNo
18747220Full Coverage Abdominal Anatomic Hernia MeshJune 2024January 2026Allow1900NoNo
18718746ELECTROSURGICAL INSTRUMENTJune 2024November 2024Allow500NoNo
18714386RECYCLING DOCKING ASSEMBLY, CONVEYING APPARATUS, LEADLESS PACEMAKER, AND PACEMAKER SYSTEMMay 2024February 2026Allow2110YesNo
18676055CHRONIC TOTAL OCCLUSION CROSSING DEVICES AND METHODSMay 2024October 2025Abandon1710NoNo
18676105HEMOSTASIS CLIP REDUCED LENGTH DEPLOYMENT MECHANISMMay 2024June 2025Allow1310NoNo
18665380DIRECTIONAL ASPIRATIONMay 2024September 2025Allow1600NoNo
18664575IMPLANTABLE DEVICES, SYSTEMS AND METHODS FOR CLOSING APERTUREMay 2024June 2025Allow1300NoNo
18662232Sinus Dilation CatheterMay 2024January 2026Allow2110NoNo
18644723OCCLUDER WITH ACCESS PASSAGE AND CLOSURE THEREOFApril 2024April 2025Allow1200NoNo
18638861TROCAR SITE CLOSURE CLIPApril 2024June 2025Allow1410YesNo
18603125ACCESS CLOSURE WITH BLEED MONITORINGMarch 2024December 2024Allow900NoNo
18602564SURGICAL FASTENERS FOR ARTICULATING SURGICAL INSTRUMENTSMarch 2024November 2024Allow800NoNo
18602096SHAFT DEFLECTION CONTROL ASSEMBLY FOR ENT GUIDE INSTRUMENTMarch 2024September 2025Allow1810NoNo
18581784ADJUSTABLE VASCULAR CLOSURE DEVICE ASSEMBLYFebruary 2024December 2024Allow1000NoNo
18684712CHITOSAN TUBULAR MEMBER AND METHOD OF PRODUCINGFebruary 2024October 2024Allow800NoNo
18291699ARTICULATED MEMBERJanuary 2024January 2026Allow2400YesNo
18416581OSCILLATING LITHOTRIPTERJanuary 2024January 2026Allow2410NoNo
18413313BLUNT DISSECTOR, DELIVERY AND DEPLOYMENT DEVICE FOR DELIVERY AND DEPLOYMENT OF SURGICAL MESH DURING SOFT TISSUE REPAIRSJanuary 2024April 2024Allow300YesNo
18579427DISCHARGE CONTROLLABLE SHOCK WAVE BALLOON CATHETER SYSTEMJanuary 2024August 2025Allow1900NoNo
18408301REPLACEABLE SURGICAL SCISSOR BLADES FOR SURGICAL INSTRUMENTSJanuary 2024August 2025Allow1900NoNo
18403540Full Coverage Abdominal Anatomic Hernia MeshJanuary 2024July 2025Allow1800NoNo
18389881Adapter And Methods For Coupling A Surgical Handpiece To A Control ConsoleDecember 2023June 2025Allow1800YesNo
18541923CALIBRATED POWER-DRIVEN SURGICAL CUTTING DEVICEDecember 2023January 2026Allow2510NoNo
18521013IMPLANTABLE INTRALUMINAL DEVICENovember 2023October 2024Allow1100NoNo
18517426SUCTION CANNULA FOR REMOVAL OF DUCT BLOCKAGENovember 2023March 2025Allow1610NoNo
18513113SECURING A GUIDEWIRE DELIVERY CATHETER IN THE CORONARY SINUS USING A MECHANICALLY RELEASING ARMNovember 2023February 2026Allow2710YesNo
18512009TRANSCATHETER DEVICES AND METHODS FOR REPAIRING A LEAFLET OF A HEART VALVE OF A SUBJECTNovember 2023December 2025Allow2500YesNo
18509864SYSTEMS, DEVICES, AND METHODS FOR JOINT FUSIONNovember 2023September 2024Allow1010YesNo
18510296HEMOSTASIS CLIP WITH COLLAPSIBLE CAPSULENovember 2023December 2024Allow1310NoNo
18509117Knotless Orthopedic Stabilization SystemNovember 2023October 2024Allow1100NoNo
18493558OCCLUDER WITH ACCESS PASSAGE AND CLOSURE THEREOFOctober 2023February 2024Allow410YesNo
18383300SUTURE BASED CLOSURE DEVICEOctober 2023November 2025Allow2420NoNo
18381925SINGLE-LOOP OR MULTIPLE-LOOP SNARE AND METHOD OF FORMING SAMEOctober 2023August 2024Allow1000NoNo
18382016CATHETER-BASED SYSTEM FOR DELIVERY AND RETRIEVAL OF A LEADLESS PACEMAKEROctober 2023September 2024Allow1100NoNo
18488126MEDICAL DELIVERY DEVICES, ASSEMBLIES, AND RELATED METHODSOctober 2023October 2025Allow2400NoNo
18555859APPARATUSES FOR REMOVING OBSTRUCTIVE MATERIAL FROM BODY LUMENSOctober 2023October 2025Allow2430NoNo
18380582APPARATUS FOR SUTURE MANAGEMENT AND METHODS THEREOFOctober 2023April 2025Allow1810NoNo
18483848METHOD AND APPARATUS FOR TISSUE GRAFTING AND COPYINGOctober 2023October 2025Allow2410NoNo
18375902INTRODUCER SHEATH WITH EXPANDABLE INTRODUCEROctober 2023May 2025Allow1920NoNo
18553515AN ELECTROCEUTICAL PATCH AND CATHETER SYSTEM AND USES THEREOFSeptember 2023September 2025Allow2400YesNo
18552147ELECTRODE BALLOON CATHETER AND HIGH-VOLTAGE GENERATION PROCESSING DEVICESeptember 2023January 2026Allow2810NoNo
18464362Obstruction Retrieval DevicesSeptember 2023March 2026Allow3020NoNo
18241529PRESSURE PROFILE MAGNETIC COMPRESSION ANASTOMOSIS DEVICESSeptember 2023April 2024Allow800YesNo
18230843SURGICAL ROBOTIC SYSTEM WITH INSTRUMENT DETECTIONAugust 2023July 2025Allow2300NoNo
18360176ROBOTIC SURGICAL ASSEMBLYJuly 2023August 2024Allow1300NoNo
18273233INSERTABLE DEVICE INCLUDING FLEXIBLE CIRCUITRYJuly 2023February 2026Allow3110NoNo
18337092Suturing Device for Laparoscopic ProceduresJune 2023August 2024Allow1400NoNo
18210156EUSTACHIAN TUBE DILATION CATHETER WITH DEPTH INDICIAJune 2023December 2025Allow3010NoNo
18328844EMBOLIC PROTECTION DEVICEJune 2023August 2025Abandon2710NoNo
18328373TISSUE RETRIEVAL SYSTEM WITH RETENTION FEATURESJune 2023December 2024Allow1810NoNo
18321495PROSTHETIC IMPLANT DELIVERY DEVICE WITH INTRODUCER CATHETERMay 2023April 2025Allow2330NoNo
18311103SYSTEMS, DEVICES, AND METHODS FOR JOINT FUSIONMay 2023August 2023Allow300NoNo
18141183LEADLESS CARDIAC PACING DEVICESApril 2023July 2024Allow1500NoNo
18309607DEVICE FOR ATRIAL APPENDAGE EXCLUSIONApril 2023October 2025Allow3020NoNo
18298905ENDOSCOPIC SNARE DEVICEApril 2023December 2024Allow2010NoNo
18127255HEMORROHOIDECTOMY LINEAR STAPLERMarch 2023April 2025Abandon2441NoNo
18186864DEVICE AND METHOD OF CREATING A FLUID CONTAINMENT FIELD FOR ADMINISTERING THERAPEUTICS TO A NERVEMarch 2023April 2025Allow2510NoNo
18107969SYNTHETIC PROSTHESIS COMPRISING A KNIT AND A NON POROUS FILM AND METHOD FOR FORMING SAMEFebruary 2023November 2024Allow2100YesNo
18149496MYRINGOTOMY TOOL WITH MULTIPLE TOOL HEADSJanuary 2023October 2024Allow2110NoNo
18090252ACCESSORY DEVICES FOR USE WITH CATHETERSDecember 2022August 2025Abandon3220NoNo
18145691TORQUEABLE DEVICES AND METHODS FOR REMOVING AN EMBOLUSDecember 2022March 2026Allow3920YesNo
18069482Choking Intervention DeviceDecember 2022May 2025Allow2900NoNo
18084008ENDOSCOPIC TREATMENT TOOLDecember 2022November 2025Abandon3520YesNo
18078001REDEPLOYABLE TISSUE RETRIEVAL SYSTEMDecember 2022September 2024Allow2110NoNo
18073443DELIVERY SYSTEMS FOR CONTROL OF GASTROINTESTINAL BLEEDINGDecember 2022October 2025Abandon3511NoNo
17993753Systems and Methods for Lead DeliveryNovember 2022September 2025Allow3411NoNo
17989632SYSTEM AND METHOD FOR LAPAROSCOPIC REPAIR OF ABDOMINAL WALL HERNIA USING UMBRELLA MESHNovember 2022February 2023Allow300NoNo
17999037LIFTING BANDNovember 2022July 2025Allow3210NoNo
17960604Surgical system having a surgical instrument controlled based on comparison of sensor and database dataOctober 2022June 2025Allow3211NoNo
17885525TRANSLUMINAL ANGIOPLASTY DEVICES AND METHODS OF USEAugust 2022April 2024Allow2100NoNo
17885522TRANSLUMINAL ANGIOPLASTY DEVICES AND METHODS OF USEAugust 2022July 2024Allow2310NoNo
17879534Occluder Pushing Device and Transport SystemAugust 2022April 2025Allow3210NoNo
17869045LOW-FRICTION, SMALL PROFILE MEDICAL TOOLS HAVING EASY-TO-ASSEMBLE COMPONENTSJuly 2022September 2024Allow2600NoNo
17863905ARTICULATING SURGICAL INSTRUMENTSJuly 2022December 2024Allow2910YesNo
17862119IMPLANTABLE PROSTHESISJuly 2022August 2024Allow2510NoNo
17856553OCCLUDER WITH ACCESS PASSAGE AND CLOSURE THEREOFJuly 2022May 2024Allow2220NoNo
17851984DEVICES AND METHODS FOR PREPARING A VALVE FOR A TRANSCATHETER VALVE REPLACEMENT PROCEDUREJune 2022December 2025Allow4110NoNo
17809187System and Methods For Sealing a Channel In TissueJune 2022April 2024Allow2200NoNo
17809153HEMOSTASIS CLIP REDUCED LENGTH DEPLOYMENT MECHANISMJune 2022February 2024Allow2000NoNo
17843356DEVICES, SYSTEMS, AND METHODS FOR ANCHORING SUTURESJune 2022October 2024Allow2810NoNo
17842456METHOD AND APPARATUS FOR PROVIDING INCREASED VISUALIZATION AND MANIPULATION OF A BODY SIDE WALLJune 2022June 2024Allow2400NoNo
17833845NEEDLE LOADER DEVICES AND RELATED SYSTEMS AND METHODSJune 2022May 2025Allow3511YesNo
17832814SURGICAL DELIVERY DEVICES, SYSTEMS, AND METHODSJune 2022May 2024Allow2410NoNo
17805659Method Of Accessing A Heart With A Hemostatic Device And An InterfaceJune 2022March 2025Allow3410NoNo
17805165SYSTEMS, DEVICES, AND METHODS FOR JOINT FUSIONJune 2022January 2023Allow810NoNo
17750985PERCUTANEOUS WOUND BARRIERMay 2022July 2023Abandon1320NoNo
17745354MEDICAL IMPLANT DELIVERY SYSTEM AND RELATED METHODSMay 2022July 2025Allow3830YesNo
17723984Variable Length Telescoping Application Tips for Flowable Hemostats and Sealants ApplicationApril 2022July 2023Allow1510NoNo
17714355BALLOON ASSEMBLY FOR USE IN A HEMOSTASIS BANDApril 2022March 2025Allow3520NoNo
17712208BLOOD CLOT REMOVAL DEVICE, SYSTEM, AND METHODApril 2022February 2024Allow2210NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner GABR, MOHAMED GAMIL.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
2
Examiner Affirmed
2
(100.0%)
Examiner Reversed
0
(0.0%)
Reversal Percentile
20.2%
Lower than average

What This Means

With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
10
Allowed After Appeal Filing
0
(0.0%)
Not Allowed After Appeal Filing
10
(100.0%)
Filing Benefit Percentile
10.8%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner GABR, MOHAMED GAMIL - Prosecution Strategy Guide

Executive Summary

Examiner GABR, MOHAMED GAMIL works in Art Unit 3771 and has examined 394 patent applications in our dataset. With an allowance rate of 86.5%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 30 months.

Allowance Patterns

Examiner GABR, MOHAMED GAMIL's allowance rate of 86.5% places them in the 65% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.

Office Action Patterns

On average, applications examined by GABR, MOHAMED GAMIL receive 1.41 office actions before reaching final disposition. This places the examiner in the 22% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by GABR, MOHAMED GAMIL is 30 months. This places the examiner in the 62% percentile for prosecution speed. Prosecution timelines are slightly faster than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +17.0% benefit to allowance rate for applications examined by GABR, MOHAMED GAMIL. This interview benefit is in the 58% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 36.2% of applications are subsequently allowed. This success rate is in the 82% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 31.4% of cases where such amendments are filed. This entry rate is in the 46% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 22% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 66.7% of appeals filed. This is in the 52% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 61.0% are granted (fully or in part). This grant rate is in the 65% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 45% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 48% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • RCEs are effective: This examiner has a high allowance rate after RCE compared to others. If you receive a final rejection and have substantive amendments or arguments, an RCE is likely to be successful.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.